Related references
Note: Only part of the references are listed.Different cytokine patterns associate with melancholia severity among inpatients with major depressive disorder
Lucas Primo de Carvalho Alves et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)
Accuracy of brain-derived neurotrophic factor levels for differentiating between Taiwanese patients with major depressive disorder or schizophrenia and healthy controls
Yu-Jie Chiou et al.
PLOS ONE (2019)
Abnormal Brain-Derived Neurotrophic Factor Exon IX Promoter Methylation, Protein, and mRNA Levels in Patients with Major Depressive Disorder
Men-Ting Hsieh et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation
Manish K. Jha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Antidepressant treatment increased serum miR-183 and miR-212 levels in patients with major depressive disorder
Chin-Chuen Lin et al.
PSYCHIATRY RESEARCH (2018)
Biomarkers for depression: recent insights, current challenges and future prospects
Rebecca Strawbridge et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
Ethnic differences in the serum levels of proBDNF, a precursor of brain-derived neurotrophic factor (BDNF), in mood disorders
Kenji Hashimoto
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2016)
A naturalistic study of high-dose unilateral ECT among severely depressed inpatients: how does it work in the clinical practice?
Lucas P. C. Alves et al.
BMC PSYCHIATRY (2016)
Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF)
Thiago Fernando Vasconcelos Freire et al.
BRAIN RESEARCH BULLETIN (2016)
Combining ECT with pharmacological treatment of depressed inpatients in a naturalistic study is not associated with serum BDNF level increase
Thiago Fernando Vasconcelos Freire et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
Brain-derived neurotrophic factor increase during treatment in severe mental illness inpatients
G. L. Nuernberg et al.
TRANSLATIONAL PSYCHIATRY (2016)
Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses
Mike C. Jentsch et al.
BIOMARKERS IN MEDICINE (2015)
Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
Rita Haapakoski et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates
Sarel J. Brand et al.
CURRENT NEUROPHARMACOLOGY (2015)
Inflammation and clinical response to treatment in depression: A meta-analysis
R. Strawbridge et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based bionnarkers
Bhautesh D. Jani et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2015)
Biochemical markers subtyping major depressive disorder
Hiroshi Kunugi et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2015)
Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: A study of two independent cohorts
Kristoffer Sodersten et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)
M. L. Molendijk et al.
MOLECULAR PSYCHIATRY (2014)
BDNF blood levels after electroconvulsive therapy in patients with mood disorders: A systematic review and meta-analysis
Andre R. Brunoni et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2014)
EFFICACY AND ACCEPTABILITY OF HIGH FREQUENCY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (rTMS) VERSUS ELECTROCONVULSIVE THERAPY (ECT) FOR MAJOR DEPRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS
Marcelo T. Berlim et al.
DEPRESSION AND ANXIETY (2013)
CRP, IL-6 and depression: A systematic review and meta-analysis of longitudinal studies
Vyara Valkanova et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders
Sinead M. Gibney et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Diagnostic accuracy of serum brain derived neurotrophic factor concentration in antidepressant naive patients with first major depression episode
Dalibor Karlovic et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only
Mohammad Haghighi et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
The neurobiology of depression and antidepressant action
Paul Willner et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Depressive symptoms and white blood cell count in coronary heart disease patients: Prospective findings from the Heart and Soul Study
Hester E. Duivis et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010
Alize J. Ferrari et al.
PLOS MEDICINE (2013)
Measurement Methods of BDNF Levels in Major Depression: A Qualitative Systematic Review of Clinical Trials
Stefania Pigatto Teche et al.
PSYCHIATRIC QUARTERLY (2013)
Psychiatric Diagnosis: Lessons from the DSM-IV Past and Cautions for the DSM-5 Future
Allen J. Frances et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 8 (2012)
A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity
Sarah A. Hiles et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression
Yang Liu et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Major depressive disorder: new clinical, neurobiological, and treatment perspectives
David J. Kupfer et al.
LANCET (2012)
Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
Taisuke Yoshida et al.
PLOS ONE (2012)
The heterogeneity of the depressive syndrome: when numbers get serious
S. D. Ostergaard et al.
ACTA PSYCHIATRICA SCANDINAVICA (2011)
Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research
Anna Meijer et al.
GENERAL HOSPITAL PSYCHIATRY (2011)
Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder
Sjoerd B. A. H. A. Fluitman et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
Should We Expect Neural Signatures for DSM Diagnoses?
Seth J. Gillihan et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Heath D. Schmidt et al.
NEUROPSYCHOPHARMACOLOGY (2011)
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
Jonas Hannestad et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Depression, Antidepressants, and Neurogenesis: A Critical Reappraisal
Nicola D. Hanson et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Serum BDNF levels before treatment predict SSRI response in depression
Owen M. Wolkowitz et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Depression and Hypothalamic-Pituitary-Adrenal Activation: A Quantitative Summary of Four Decades of Research
Cinnamon Stetler et al.
PSYCHOSOMATIC MEDICINE (2011)
Inflammatory Biomarkers in Depression: An Opportunity for Novel Therapeutic Interventions
Madeline Li et al.
CURRENT PSYCHIATRY REPORTS (2011)
The Diagnosis of Mental Disorders: The Problem of Reification
Steven E. Hyman
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 6 (2010)
Inflammation, Sanitation, and Consternation Loss of Contact With Coevolved, Tolerogenic Microorganisms and the Pathophysiology and Treatment of Major Depression
Charles L. Raison et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
Serum levels of brain-derived neurotrophic factor in drug-naive obsessive-compulsive patients: A case-control study
Giuseppe Maina et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Regulatory T cells increased while IL-1β decreased during antidepressant therapy
Hubertus Himmerich et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions
Kenji Hashimoto
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2010)
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses
Luisella Bocchio-Chiavetto et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Andrew H. Miller et al.
BIOLOGICAL PSYCHIATRY (2009)
CLINICAL TRIAL OF ADJUNCTIVE CELECOXIB TREATMENT IN PATIENTS WITH MAJOR DEPRESSION: A DOUBLE BLIND AND PLACEBO CONTROLLED TRIAL
Shahin Akhondzadeh et al.
DEPRESSION AND ANXIETY (2009)
Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): A pilot study in drug resistant depressed patients
Brisa Fernandes et al.
NEUROSCIENCE LETTERS (2009)
Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
M. Bryant Howren et al.
PSYCHOSOMATIC MEDICINE (2009)
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications
Srijan Sen et al.
BIOLOGICAL PSYCHIATRY (2008)
Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders
P. Monteleone et al.
BIPOLAR DISORDERS (2008)
Role of the brain-derived neurotrophic factor at glutamatergic synapses
A. L. Carvalho et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression
Andre Russowsky Brunoni et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Increase in plasma-proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder
Kai Lehtimaki et al.
JOURNAL OF ECT (2008)
Serum brain-derived neurotrophic factor levels in patients with major depression: Effects of antidepressants
Tiao-Lai Huang et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine
Francesco Matrisciano et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: A pilot study
Tatsuya Okamoto et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia
Yumiko Ikeda et al.
SCHIZOPHRENIA RESEARCH (2008)
Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease
T. Leyhe et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2008)
Interaction between BDNF and serotonin: Role in mood disorders
Keri Martinowich et al.
NEUROPSYCHOPHARMACOLOGY (2008)
T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression
Tiao-Lai Huang et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2007)
Measurements of brain-derived neurotrophic factor: Methodological aspects and demographical data
Viktorija Trajkovska et al.
BRAIN RESEARCH BULLETIN (2007)
Depressive disorders and immunity: 20 years of progress and discovery
Michael R. Irwin et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: A pilot study in patients with major depression
Christopher M. Marano et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania
Tiao-Lai Huang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Childhood maltreatment predicts adult inflammation in a life-course study
Andrea Danese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Consensus paper of the WFSBP task force on biological markers: Biological markers in depression
Rainald Moesner et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2007)
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients
Luisella Bocchio-Chiavetto et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women
Cigdem Aydemir et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Neuratrophin-regulated signalling pathways
Louis F. Reichardt
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2006)
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression:: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
N Müller et al.
MOLECULAR PSYCHIATRY (2006)
Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: The Chicago health, aging, and social relations study
Thomas W. McDade et al.
PSYCHOSOMATIC MEDICINE (2006)
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients
R Zanardini et al.
JOURNAL OF AFFECTIVE DISORDERS (2006)
Cytokines sing the blues: inflammation and the pathogenesis of depression
CL Raison et al.
TRENDS IN IMMUNOLOGY (2006)
Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients
AS Gonul et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2005)
Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity
F Karege et al.
BIOLOGICAL PSYCHIATRY (2005)
The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study
O Aydemir et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode
N Gervasoni et al.
NEUROPSYCHOBIOLOGY (2005)
Raised plasma levels of tumor necrosis factor α in patients with depression -: Normalization during electroconvulsive therapy
KA Hestad et al.
JOURNAL OF ECT (2003)
Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects
Y Dwivedi et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants
E Shimizu et al.
BIOLOGICAL PSYCHIATRY (2003)
Molecular correlates of impaired prefrontal plasticity in response to chronic stress
SD Kuipers et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Decreased serum brain-derived neurotrophic factor levels in major depressed patients
F Karege et al.
PSYCHIATRY RESEARCH (2002)
The relationship of depression and stressors to immunological assays: A meta-analytic review
EP Zorrilla et al.
BRAIN BEHAVIOR AND IMMUNITY (2001)
Cytokines and the brain: Implications for clinical psychiatry
Z Kronfol et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Share Paper
